942 The tumor microbiome correlates with response to immune checkpoint inhibitors in renal cell carcinoma von Wheeler, Caroline, Yang, Yuanquan, Spakowicz, Daniel, Hoyd, Rebecca, Li, Mingjia

Volltext

12 Belimumab helps lupus patients to achieve lupus targets von Doria, Andrea

Volltext

244 Novel respirable antisense oligonucleotide (RASON) approach to primary and metastatic human lung cancer: preliminary results in a model system employing spontaneous lung tumors... von Nyce, Jonathan

Volltext

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics von Kurrikoff, Kaido, Vunk, Birgit, Langel, Ülo

Volltext

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics von Saini, Kamal S, Punie, Kevin, Twelves, Chris, Bortini, Stefanella, de Azambuja, Evandro, Anderson, Steven, Criscitiello, Carmen, Awada, Ahmad, Loi, Sherene

Volltext

Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy von Enell Smith, Karin, Deronic, Adnan, Hägerbrand, Karin, Norlén, Per, Ellmark, Peter

Volltext

Facing the future: challenges and opportunities in adoptive T cell therapy in cancer von Magalhaes, Isabelle, Carvalho-Queiroz, Claudia, Hartana, Ciputra Adijaya, Kaiser, Andreas, Lukic, Ana, Mints, Michael, Nilsson, Ola, Grönlund, Hans, Mattsson, Jonas, Berglund, Sofia

Volltext

A health economic guide to market access of biosimilars von Simoens, Steven, Vulto, Arnold G

Volltext

MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases von Cortez, Maria Angelica, Calin, George Adrian

Volltext

Next-generation CD40 agonists for cancer immunotherapy von Andersson, Hampus, Nyesiga, Barnabas, Hermodsson, Tova, Smith, Karin Enell, Hagerbrand, Karin, Lindstedt, Malin, Ellmark, Peter

Volltext

Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway von Goll, Guro Løvik, Kvien, Tore Kristian Aaserud

Volltext

Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view von Cimadamore, Alessia, Scarpelli, Marina, Massari, Francesco, Eckstein, Markus, Gevaert, Thomas, Cheng, Liang, Lopez-Beltran, Antonio, Montironi, Rodolfo

Volltext

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility von Dodd, Seetal, Dean, Olivia, Copolov, David L, Malhi, Gin S, Berk, Michael

Volltext

Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance von Meijboom, Rosanne W, Barbier, Liese, Druedahl, Louise C, Sarnola, Kati, Tolonen, Hanna M, Gardarsdottir, Helga, Egberts, Acg, Giezen, Thijs J

Volltext

The wound-healing and antioxidant effects of adipose-derived stem cells von Kim, Won-Serk, Park, Byung-Soon, Sung, Jong-Hyuk

Volltext

Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease von Bislenghi, G, Wolthuis, A, Van Assche, G, Vermeire, S, Ferrante, M, D'Hoore, A

Volltext

Smoking reduces the efficacy of belimumab in mucocutaneous lupus von Parodis, Ioannis, Gomez, Alvaro, Frodlund, Martina, Jönsen, Andreas, Zickert, Agneta, Sjöwall, Christoffer, Bengtsson, Anders A, Gunnarsson, Iva

Volltext

Biofunctionalized targeted nanoparticles for therapeutic applications von Wang, Andrew Z, Gu, Frank, Zhang, Liangfang, Chan, Juliana M, Shaikh, Mariam R, Farokhzad, Omid C

Volltext

Tumor localized agonistic anti-CD40 therapy and beyond von Eltahir, Mohamed, Persson, Helena, Mangsbo, Sara

Volltext

Antibody therapeutics: isotype and glycoform selection von Jefferis, Roy

Volltext